Oncascan Developing UVA Technology to Reduce Number of Cancer Biopsies | GenomeWeb

NEW YORK(GenomeWeb) – Leveraging technology from the University of Bradford, a UK firm is developing a blood-based screening test for cancer that could reduce the number of unnecessary biopsies and other procedures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.